BC
VRTX icon

Burney Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Burney Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
2,129
-2,681
-56% -$1.19M 0.03% 343
2026
Q1 		$2.15M Sell
4,810
-658
-12% -$307K 0.07% 214
2025
Q4 		$2.48M Sell
5,468
-1,163
-18% -$501K 0.08% 214
2025
Q3 		$2.6M Sell
6,631
-32,500
-83% -$13.6M 0.08% 207
2025
Q2 		$17.4M Buy
39,131
+326
+0.8% +$150K 0.59% 43
2025
Q1 		$18.8M Buy
38,805
+1,038
+3% +$484K 0.68% 35
2024
Q4 		$15.2M Sell
37,767
-8,394
-18% -$3.89M 0.54% 44
2024
Q3 		$21.5M Buy
46,161
+7,332
+19% +$3.52M 0.76% 27
2024
Q2 		$18.2M Buy
38,829
+37,997
+4,567% +$16.5M 0.7% 30
2024
Q1 		$348K Sell
832
-5,666
-87% -$2.4M 0.01% 502
2023
Q4 		$2.64M Buy
6,498
+5,815
+851% +$2.15M 0.11% 201
2023
Q3 		$238K Buy
683
+58
+9% +$20.3K 0.01% 513
2023
Q2 		$220K Buy
+625
New +$211K 0.01% 535
2023
Q1 		– Sell
-5,639
Closed -$1.63M – 579
2022
Q4 		$1.63M Buy
5,639
+295
+6% +$89.9K 0.08% 227
2022
Q3 		$1.55M Buy
5,344
+4,440
+491% +$1.28M 0.09% 237
2022
Q2 		$255K Sell
904
-93
-9% -$24.9K 0.01% 492
2022
Q1 		$260K Buy
+997
New +$237K 0.01% 516
2021
Q1 		– Sell
-1,893
Closed -$447K – 579
2020
Q4 		$447K Sell
1,893
-133
-7% -$30.5K 0.02% 387
2020
Q3 		$551K Buy
+2,026
New +$559K 0.03% 344

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Burney Company's VRTX Position: Q2 2026 in Review

Burney Company reduced its Vertex Pharmaceuticals (VRTX) stake by 56% in Q2 2026, selling an estimated $1.19M and leaving 2,129 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #343.

Burney Company first reported a position in VRTX in Q3 2020 and has held it in 19 quarters since. The position peaked at $21.5M in Q3 2024. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Burney Company held 2,129 shares of Vertex Pharmaceuticals worth $1.06M as of Q2 2026.
  • Burney Company sold 2,681 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.19M.
  • Vertex Pharmaceuticals made up 0.03% of Burney Company's portfolio in Q2 2026, its #343 holding.
  • Burney Company first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • Burney Company's Vertex Pharmaceuticals position peaked at $21.5M in Q3 2024.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.